1Singh N, Arnow PM, Bonham A, et al. Invasive aspergillosis in liver transplant recipients in the 1990 [ J ]. Transplantation, 1997,64 (5) : 716 -720.
2Brown RS Jr, Lake JR, Katzman BA, et al. Incidence and significance of aspergillus cultures following liver and kidney transplantation [ J ]. Transplantation, 1996,61 (4) : 666-669.
2Fortun J,Martin-Davila P,Moreno S,et al.Risk factors for invasive aspergillosis in liver transplant recipients.Liver Transpl,2002,8:1065 -1070.
3Fortun J,Martin-Davila P,de Vicente E,et al.Prophylaxis with oral fluconazole and an oral solution of amphotericin B in liver transplant patients.Transplant Proc,2002,34:80-81.
4Singhal S,Ellis RW,Jones SG,et al.Targeted prophylaxis with amphotericin B lipid complex in liver transplantation.Liver Transpl,2000,6:588-595.
5Herbrecht R,Denning DW,Patterson TF,et al.Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.N Engl J Med,2002,347:408-415.
6Maertens J,Raad I,Petrikkos G,et al.Poster M-868.The 42nd Interscience Coferenee on Antimicrobial Agents and Chemotherapy,San Diego,2002.
7Linden PK,Coley K,Fontes P,et al.Invasive aspergillosis in liver transplant recipients:outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B.Clin Infect Dis,2003,37:17-25.
